| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Revenue | $3.0M | $0 | $0 | — | — | $0 |
| Cost of revenue | $17.0M | $0 | $0 | — | — | — |
| Research and development | $745.0M+10.2% | $676.0M-5.6% | $716.0M-100.0% | $677.00T-2.9% | $697.00T+389385374.9% | $179.0M |
| Selling, general and administrative | $142.0M+29.1% | $110.0M-7.6% | $119.0M-100.0% | $129.00T+11.2% | $116.00T+297435797.4% | $39.0M |
| Loss from operations | -$901.0M-14.6% | -$786.0M+5.9% | -$835.0M+100.0% | -$1852.00T-153.4% | -$731.00T-335321000.9% | -$218.0M |
| Change in fair value of derivative liabilities | $29.0M+220.8% | -$24.0M-20.0% | -$20.0M-100.0% | $114.00T+670.0% | -$20.00T | $0 |
| Other income, net | $56.0M-9.7% | $62.0M+5.1% | $59.0M-100.0% | $15.00T+266.7% | -$9.00T-225000100.0% | $4.0M |
| Loss before income taxes | -$816.0M-9.1% | -$748.0M+6.0% | -$796.0M+100.0% | -$1723.00T-126.7% | -$760.00T-355140086.9% | -$214.0M |
| Income tax expense | $0 | $0 | $0 | $0+100.0% | -$5.00T | $0 |
| Net loss | -$816.0M-9.1% | -$748.0M+6.0% | -$796.0M+100.0% | -$1723.00T-128.2% | -$755.00T-352803638.3% | -$214.0M |
| Basic net loss per share (in usd per share) | -$440000.00+4.3% | -$460000.00+23.3% | -$600000.00+60.3% | -$1510000.00-23.8% | -$1220000.00-154430279.7% | -$0.79 |
| Diluted net loss per share (in usd per share) | -$440000.00+4.3% | -$460000.00+23.3% | -$600000.00+60.3% | -$1510000.00-23.8% | -$1220000.00-154430279.7% | -$0.79 |
| Basic weighted-average shares outstanding (in shares) | 1.84B+13.7% | 1.62B+21.9% | 1.33B+16.1% | 1.14B+84.1% | 621.0M+129.2% | 271.0M |
| Diluted weighted-average shares outstanding (in shares) | 1.84B+13.7% | 1.62B+21.9% | 1.33B+16.1% | 1.14B-99.8% | 620.82B+129.1% | 270.94B |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Source: SEC EDGAR 10-K and 10-Q filings. Up to 10 years annual / 16 quarters shown.